Salacetamide

DB20217InvestigationalSmall molecule

Salacetamide is a small molecule drug. Salacetamide is under investigation in clinical trial NCT00220285 (Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma).... Salacetamide has a monoisotopic molecular weight of 179.06 Da.

Formula / weight: C₉H₉NO₃ · 179.175 g/mol (avg)
Code names: L-749 · NSC-40153

Resolves to

Compound

UNII7G29CRR596CAS487-48-9ChEMBLCHEMBL1709559ChEBI134815

Structure

InChIKeyJZWFDVDETGFGFC-UHFFFAOYSA-NSMILESCC(=O)NC(=O)C1=C(O)C=CC=C1

What you can answer from here — as of September 20, 2026

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Salacetamide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account